ARTERX SURGICAL SEALANT

Sealant, Polymerizing

FDA Premarket Approval P100030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the arterx surgical sealant. This device is indicated for use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.

DeviceARTERX SURGICAL SEALANT
Classification NameSealant, Polymerizing
Generic NameSealant, Polymerizing
ApplicantBaxter Healthcare Corporation
Date Received2010-07-27
Decision Date2013-03-01
Notice Date2013-03-14
PMAP100030
SupplementS
Product CodeNBE
Docket Number13M-0281
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Baxter Healthcare Corporation one Baxter Parkway deerfield, IL 60015
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P100030Original Filing
S016 2021-11-10 30-day Notice
S015 2021-06-28 30-day Notice
S014 2020-09-14 Real-time Process
S013
S012
S011 2017-07-31 30-day Notice
S010 2017-07-26 30-day Notice
S009 2017-07-07 135 Review Track For 30-day Notice
S008 2017-07-03 Panel Track
S007 2017-05-30 Real-time Process
S006
S005 2016-07-26 Normal 180 Day Track No User Fee
S004 2014-05-22 Normal 180 Day Track No User Fee
S003
S002 2013-09-03 Real-time Process
S001 2013-09-03 Real-time Process

NIH GUDID Devices

Device IDPMASupp
25413765583609 P100030 013
25413765583593 P100030 013
25413765583586 P100030 013
25413765583524 P100030 014

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.